Skip to main content
. 2021 Oct 2;12(22):6894–6904. doi: 10.7150/jca.54556

Figure 5.

Figure 5

VPS9D1-AS1 affects ESCC via the Wnt/β-catenin signaling pathway. (A) Knockdown of VPS9D1-AS1 reduced the expression of key proteins in Eca109 and TE-13 cells, while Wnt/β-catenin pathway agonist CT99021 alleviated this effect. (B) Knockdown of VPS9D1-AS1 inhibited the colony‐forming ability in Eca109 and TE-13 cells, while CT99021 alleviated this effect. (C) The expression of VPS9D1-AS1 was positively correlated with β-catenin and c-Myc in ESCC tissue samples. (Data are mean±SD.*P<.05, **P<.01, ***P<.001, and ****P<.0001).